GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aibotics Inc (OTCPK:AIBT) » Definitions » Notes Receivable

AIBT (Aibotics) Notes Receivable : $0.00 Mil (As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Aibotics Notes Receivable?

Aibotics's Notes Receivable for the quarter that ended in Sep. 2024 was $0.00 Mil.


Aibotics Notes Receivable Historical Data

The historical data trend for Aibotics's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aibotics Notes Receivable Chart

Aibotics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Notes Receivable
Get a 7-Day Free Trial - - - - -

Aibotics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Aibotics Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Aibotics Notes Receivable Related Terms

Thank you for viewing the detailed overview of Aibotics's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Aibotics Business Description

Traded in Other Exchanges
N/A
Address
100 SE 2nd Street, Suite 2000, Miami, FL, USA, 33131
Aibotics Inc is a holding company specializing in artificial intelligence and robotics. The company focuses on developing, investing in, and managing a diverse portfolio of companies and technologies in industries.
Executives
Mark D. Williams director, 10 percent owner, officer: President, CEO & CFO 480 22ND STREET, BOX 2, HEYBURN ID 83336
Gibson Colin director, 10 percent owner, officer: Vice President 480 22ND STREET, BOX 2, HEYBURN ID 83336